Cargando…
Efficacy of transoral fundoplication for treatment of chronic gastroesophageal reflux disease incompletely controlled with high-dose proton-pump inhibitors therapy: a randomized, multicenter, open label, crossover study
BACKGROUND: The aim of this randomized, crossover study was to determine if transoral fundoplication (TF) could further improve clinical outcomes in partial responders to high-dose (HD) proton-pump inhibitor (PPI) therapy and to evaluate durability of TF. METHODS: In seven United States centers, pat...
Autores principales: | Trad, Karim Sami, Simoni, Gilbert, Barnes, William Edris, Shughoury, Ahmad Bassel, Raza, Mamoon, Heise, Jeffrey Alan, Turgeon, Daniel Gilles, Fox, Mark Alan, Mavrelis, Peter George |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4287131/ https://www.ncbi.nlm.nih.gov/pubmed/25284142 http://dx.doi.org/10.1186/1471-230X-14-174 |
Ejemplares similares
-
Transoral Incisionless Fundoplication Effective in Eliminating GERD Symptoms in Partial Responders to Proton Pump Inhibitor Therapy at 6 Months: The TEMPO Randomized Clinical Trial
por: Trad, Karim S., et al.
Publicado: (2015) -
Transoral fundoplication offers durable symptom control for chronic GERD: 3-year report from the TEMPO randomized trial with a crossover arm
por: Trad, Karim S., et al.
Publicado: (2016) -
The TEMPO Trial at 5 Years: Transoral Fundoplication (TIF 2.0) Is Safe, Durable, and Cost-effective
por: Trad, Karim S., et al.
Publicado: (2018) -
Hiatal hernia repair with transoral incisionless fundoplication versus Nissen fundoplication for gastroesophageal reflux disease: A retrospective study
por: Jaruvongvanich, Veeravich K., et al.
Publicado: (2023) -
Laparoscopic Hiatal Hernia Repair Followed by Transoral Incisionless Fundoplication With EsophyX Device (HH + TIF): Efficacy and Safety in Two Community Hospitals
por: Janu, Peter, et al.
Publicado: (2019)